SAN
MATEO, Calif., Feb. 26,
2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH),
("Talphera"), a specialty pharmaceutical company focused on the
development and commercialization of innovative therapies for use
in medically supervised settings, today announced that it will
release fourth quarter and full-year 2023 financial results after
market close on Wednesday, March 6,
2024, then host a live webcast and conference call at
4:30 p.m. Eastern Standard Time/1:30
p.m. Pacific Standard Time to discuss the results and
provide an update on the Company's business.
Webcast Information
The webcast can be accessed here or by visiting the Investors
section of the Company's website at www.talphera.com and clicking
on the webcast link posted within Investors/News &
Events/Upcoming Events section. The webcast will include a slide
presentation and a replay will be available on the Talphera
website for 90 days following the event.
Conference Call Information
Investors who wish to participate in the conference call may do
so by dialing 1-800-836-8184 for North American callers, or
1-646-357-8785 (toll applies) for international callers outside of
Canada. The conference ID is
74791.
About Talphera, Inc.
Talphera, Inc. is a specialty
pharmaceutical company focused on the development and
commercialization of innovative therapies for use in medically
supervised settings. Talphera's lead product candidate,
Niyad™ is a lyophilized formulation of nafamostat and is
currently being studied under an investigational device exemption,
or IDE, as an anticoagulant for the extracorporeal circuit, and has
received Breakthrough Device Designation status from the FDA.
Talphera is also developing two pre-filled syringes in-licensed
from its partner Aguettant: Fedsyra™, a pre-filled
ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.
This release is intended for investors only. For additional
information about Talphera, please visit www.talphera.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/talphera-to-host-fourth-quarter-and-full-year-2023-financial-results-call-and-webcast-on-march-6-2024-302071538.html
SOURCE Talphera, Inc.
